These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22001129)

  • 1. Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis.
    Toulis KA; Anastasilakis AD; Polyzos SA; Makras P
    Hormones (Athens); 2011; 10(3):174-95. PubMed ID: 22001129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments.
    Dede AD; Makras P; Anastasilakis AD
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1137-1144. PubMed ID: 28836858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging anabolic treatments in osteoporosis.
    Mosekilde L; Tørring O; Rejnmark L
    Curr Drug Saf; 2011 Apr; 6(2):62-74. PubMed ID: 21524248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational anabolic therapies for osteoporosis.
    Trivedi R; Goswami R; Chattopadhyay N
    Expert Opin Investig Drugs; 2010 Aug; 19(8):995-1005. PubMed ID: 20629616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic therapies for osteoporosis.
    Uihlein AV; Leder BZ
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anabolic agents: what is beyond osteoporosis?
    Liu Y; Levack AE; Marty E; Or O; Samuels BP; Redko M; Lane JM
    Osteoporos Int; 2018 May; 29(5):1009-1022. PubMed ID: 29627891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential new drug targets for osteoporosis.
    Deal C
    Nat Clin Pract Rheumatol; 2009 Jan; 5(1):20-7. PubMed ID: 19098925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis.
    Chew CK; Clarke BL
    Maturitas; 2017 Mar; 97():53-60. PubMed ID: 28159062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.
    Canalis E
    Eur J Endocrinol; 2018 Feb; 178(2):R33-R44. PubMed ID: 29113980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances treatment of osteoporosis: new molecules, new strategies].
    Orcel P
    Bull Acad Natl Med; 2010 Nov; 194(8):1505-16; discussion 1516-8. PubMed ID: 22046713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapeutic targets for osteoporosis: beyond denosumab.
    Lim V; Clarke BL
    Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblast as a target of anti-osteoporotic treatment.
    Corrado A; Sanpaolo ER; Di Bello S; Cantatore FP
    Postgrad Med; 2017 Nov; 129(8):858-865. PubMed ID: 28770650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTH (1-34): a novel anabolic drug for the treatment of osteoporosis.
    Holick MF
    South Med J; 2005 Nov; 98(11):1114-7. PubMed ID: 16353381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update and perspectives of anabolic therapies for osteoporosis].
    Endo I; Matsumoto T
    Clin Calcium; 2012 Mar; 22(3):327-33. PubMed ID: 22370299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives.
    Baron R; Hesse E
    J Clin Endocrinol Metab; 2012 Feb; 97(2):311-25. PubMed ID: 22238383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatment modalities in osteoporosis.
    Canalis E
    Endocr Pract; 2010; 16(5):855-63. PubMed ID: 20350910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
    Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
    Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of osteoporosis treatment - a research update.
    Lippuner K
    Swiss Med Wkly; 2012; 142():w13624. PubMed ID: 22815185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone as an anabolic skeletal therapy.
    Rubin MR; Bilezikian JP
    Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.